Docetaxel Injection
Product Images NDC 70121-1221

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 70121-1221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Docetaxel Injection 1)

FDA Label Image

10 (Docetaxel Injection 10)

This text appears to be a graph or chart displaying survival probability and survival time. The survival probability is listed in percentages at various time intervals, including 24, 30, 3, 42, 48, 54, and 60 months. The survival time is only listed at 72 months. It is unclear what this data represents without additional context.*

FDA Label Image

11 (Docetaxel Injection 11)

Not-Available.*

FDA Label Image

Kj (Docetaxel Injection 12)

This is a product description for a medication called Docetaxel, available as a one-vial formulation for intravenous infusion. The product information includes dosage guidelines (10-60 cents, 20-AH), the manufacturer's address, and NDC code (70121-1221-1). The label warns that this medication is cytotoxic and is for intravenous infusion only.*

FDA Label Image

We (Docetaxel Injection 13)

This is a description of a medicine - Docetaxel Injection, USP which is used for intravenous infusion only. It is a single-dose vial and should only be added to an infusion solution. The usual dosage information is included in the package. The warning states that it is a cytotoxic agent and should be kept away from children. The content of the vial is 1 mL and should be stored at a temperature between 20°C and 25°C. The instructions also state to protect it from light. The lot number and expiration date are included on the packaging.*

FDA Label Image

Po (Docetaxel Injection 14)

This is a description for a pharmaceutical product. The text mentions "Docetaxel" in a solution of "Injection, USP" which is cytotoxic and for intravenous infusion only. It is a vial formulation with a concentration of 20 mg/mL and is ready to add to infusion solution. The National Drug Code (NDC) for this product is 70121-1222-1.*

FDA Label Image

Fg (Docetaxel Injection 15)

This is a product description for a medication called Docetaxel Injection, USP. The medication is available in a one-vial formulation of 80mg/4mL (20mg/ml). The typical dosage instructions can be found on the package. It is distributed by Amneal Pharmaceuticals LLC and manufactured by Amneal Oncology Pvt. Ltd. The medication is to be used for intravenous infusion only and is labeled as a Cytotoxic agent. It should be stored between 20-25°C and protected from light.*

FDA Label Image

Fs (Docetaxel Injection 16)

This is a description of a medication called Docetaxel Injection, USP, which is a cytotoxic drug used for intravenous infusion only. It comes in a 20mg/ml one-vial formulation that needs to be added to an infusion solution. Each ml contains 20mg docetaxel anhydrous, USP, and 0.4mg citric acid anhydrous in 50/50 (v/v) ratio of polysorbate 80/dehydrated alcohol. The usual dosage should be seen in the package insert. This medication is manufactured in India with Mfg. Lic. No. 7429/A3/2014 by Amneal Pharmaceuticals LLC located in Bridgewater, NJ 08807.*

FDA Label Image

Uy (Docetaxel Injection 17)

This is a product description for Docetaxel Injection, USP. Each mL of the injection contains 20mg of docetaxel anhydrous, USP, and 0.4mg of polysorbate 80. The vial has a strength of 160mg/8mL. The injection is a cytotoxic agent that should be kept out of the reach of children and promptly discarded after single-use. It is intended for intravenous infusion only. The product should be stored in a cool, dark place between temperatures of 20° to 25°C (68° to 77°F). Lot number and expiration date information is provided on the packaging.*

FDA Label Image

2 (Docetaxel Injection 2)

This appears to be a table, with headings "OFS Probability" and "Disease-Free Survival Time" and some additional information in the table cells. However, the table is not complete and it is not clear what the values in the table cells represent without more context.*

FDA Label Image

3 (Docetaxel Injection 3)

This appears to be a graph or data table comparing survival probability and survival time, with percentages and months as the units of measurement. However, without further context or labels, it is difficult to interpret or draw any meaningful conclusions from this information.*

FDA Label Image

4 (Docetaxel Injection 4)

The text describes a graph or chart displaying survival time in months with cumulative probabilities. There is a logarithmic calculation with a resulting p value of 0.01. The time scale on the graph spans from 6 months to 21 months in increments of 3.*

FDA Label Image

5 (Docetaxel Injection 5)

This appears to be a graph showing the cumulative probability of survival over time (months) for an unknown subject or group. The x-axis shows the months, and the y-axis shows the cumulative probability of survival. There are also some labels and values in the graph, but it is unclear what they represent without further context.*

FDA Label Image

6 (Docetaxel Injection 6)

FDA Label Image

7 (Docetaxel Injection 7)

FDA Label Image

8 (Docetaxel Injection 8)

FDA Label Image

9 (Docetaxel Injection 9)

The text represents a graph displaying the probability of progression-free survival (PFS) in percentage at different time intervals in months (36 months) for a particular medical treatment. The PFS probability is shown to increase from 6% at 6 months to 30% at 36 months.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.